Document Details

Document Type : Article In Journal 
Document Title :
Potentially Serious Lamotrigine-Related Skin Rash.
الطفح الجلدى الناتج من علاج الاميكتال
 
Document Language : English 
Abstract : Background: Lamotrigine (LTG) can be associated with an idiosyncratic, immune mediated, hypersensitivity skin rash. It can evolve to Stevens-Johnson syndrome (SJS), particularly if used with valproic acid (VPA). Our objective is to report our experience with LTG-related skin rash in children with epilepsy. Methods: Series of consecutive children with epilepsy treated with LTG were identified prospectively over a 5-year period ending 1/10/2005 at King Abdulaziz University Hospital and King Faisal Specialist Hospital and Research center, Jeddah, Saudi Arabia. Follow up by one neurologist was performed. Results: Of 207 children on LTG, 15 (7.2%) developed a skin rash with ages ranging between 3-12 years (mean 7.5). LTG was used as monotherapy in 3/15 and as add on in 12/15, mostly (10/15) in addition to VPA. The rash was mild with complete recovery in 7 children (47%). The remaining 8 (3.9% of the total) had severe rash that necessitated admission to hospital. Seven out of these 8 children were also receiving VPA. One child had superimposed secondary bacterial infection and admitted for intravenous antibiotics. Two children recovered slowly with extensive post-inflammatory hyperpigmentation. SJS was diagnosed in 5 children (2.4% of the total). One of these 5 children had progressive symptoms that evolved to toxic epidermal necrolysis. He required prolonged intensive care admission and developed sepsis with disseminated intravascular coagulopathy. He deteriorated despite of supportive therapy and died 5 weeks after the initiation of LTG therapy. Conclusions: Lamotrigine is a novel antiepileptic drug with a favorable therapeutic profile and good tolerability. LTG-related skin rash is a potentially serious adverse event that should be carefully monitored. Although the risk is small, it should be weighed against the potential benefits, particularly in children on VPA. 
ISSN : 0379-5284 
Journal Name : Neurosciences Journal 
Volume : 1 
Issue Number : 12 
Publishing Year : 2007 AH
2007 AD
 
Article Type : Article 
Added Date : Saturday, March 13, 2010 

Researchers

Researcher Name (Arabic)Researcher Name (English)Researcher TypeDr GradeEmail
محمد جانjan, Mohammed ResearcherDoctorate 

Files

File NameTypeDescription
 25895.doc doc 

Back To Researches Page